Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DMAC | Voting Common Shares, no par value per share | Purchase | $254K | +65K | +22.01% | $3.91 | 360K | Jun 23, 2023 | Direct | F1 |
transaction | DMAC | Voting Common Shares, no par value per share | Gift | $0 | -15K | -4.16% | $0.00 | 345K | Jun 23, 2023 | Direct | |
holding | DMAC | Voting Common Shares, no par value per share | 25.6K | Jun 23, 2023 | See footnote | F2 | |||||
holding | DMAC | Voting Common Shares, no par value per share | 21.1K | Jun 23, 2023 | By Spouse |
Id | Content |
---|---|
F1 | Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 64,959 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually. |
F2 | These voting common shares are held by 424822 Albert Ltd, of which Michael Giuffre has sole voting and dispositive power. |